VIATRIS INC (VTRS) Stock Fundamental Analysis

USA Nasdaq NASDAQ:VTRS • US92556V1061

14.58 USD
+0.24 (+1.67%)
At close: Feb 6, 2026
14.5 USD
-0.08 (-0.55%)
After Hours: 2/6/2026, 8:11:00 PM
Fundamental Rating

4

Taking everything into account, VTRS scores 4 out of 10 in our fundamental rating. VTRS was compared to 191 industry peers in the Pharmaceuticals industry. While VTRS is still in line with the averages on profitability rating, there are concerns on its financial health. VTRS is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • VTRS had positive earnings in the past year.
  • VTRS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VTRS reported negative net income in multiple years.
  • In the past 5 years VTRS always reported a positive cash flow from operatings.
VTRS Yearly Net Income VS EBIT VS OCF VS FCFVTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • VTRS's Return On Assets of -9.73% is fine compared to the rest of the industry. VTRS outperforms 67.54% of its industry peers.
  • VTRS has a better Return On Equity (-24.26%) than 64.92% of its industry peers.
  • With an excellent Return On Invested Capital value of 3.41%, VTRS belongs to the best of the industry, outperforming 80.63% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for VTRS is significantly below the industry average of 12.65%.
Industry RankSector Rank
ROA -9.73%
ROE -24.26%
ROIC 3.41%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
VTRS Yearly ROA, ROE, ROICVTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • Looking at the Operating Margin, with a value of 9.34%, VTRS belongs to the top of the industry, outperforming 81.68% of the companies in the same industry.
  • In the last couple of years the Operating Margin of VTRS has declined.
  • VTRS has a Gross Margin of 39.36%. This is in the better half of the industry: VTRS outperforms 61.78% of its industry peers.
  • VTRS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.34%
PM (TTM) N/A
GM 39.36%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
VTRS Yearly Profit, Operating, Gross MarginsVTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VTRS is destroying value.
  • Compared to 1 year ago, VTRS has less shares outstanding
  • The number of shares outstanding for VTRS has been increased compared to 5 years ago.
  • Compared to 1 year ago, VTRS has an improved debt to assets ratio.
VTRS Yearly Shares OutstandingVTRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VTRS Yearly Total Debt VS Total AssetsVTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • VTRS has an Altman-Z score of 1.01. This is a bad value and indicates that VTRS is not financially healthy and even has some risk of bankruptcy.
  • VTRS has a Altman-Z score of 1.01. This is comparable to the rest of the industry: VTRS outperforms 51.83% of its industry peers.
  • VTRS has a debt to FCF ratio of 8.96. This is a slightly negative value and a sign of low solvency as VTRS would need 8.96 years to pay back of all of its debts.
  • VTRS's Debt to FCF ratio of 8.96 is amongst the best of the industry. VTRS outperforms 80.10% of its industry peers.
  • VTRS has a Debt/Equity ratio of 0.82. This is a neutral value indicating VTRS is somewhat dependend on debt financing.
  • VTRS's Debt to Equity ratio of 0.82 is on the low side compared to the rest of the industry. VTRS is outperformed by 71.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.96
Altman-Z 1.01
ROIC/WACC0.42
WACC8.19%
VTRS Yearly LT Debt VS Equity VS FCFVTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that VTRS should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.35, VTRS is not doing good in the industry: 74.35% of the companies in the same industry are doing better.
  • VTRS has a Quick Ratio of 1.35. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.79, VTRS is doing worse than 83.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.79
VTRS Yearly Current Assets VS Current LiabilitesVTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

  • The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
  • VTRS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.73% yearly.
  • The Revenue has decreased by -6.14% in the past year.
  • VTRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%

3.2 Future

  • Based on estimates for the next years, VTRS will show a small growth in Earnings Per Share. The EPS will grow by 4.45% on average per year.
  • The Revenue is expected to grow by 0.49% on average over the next years.
EPS Next Y-10.82%
EPS Next 2Y-2.3%
EPS Next 3Y1.4%
EPS Next 5Y4.45%
Revenue Next Year-4.74%
Revenue Next 2Y-1.77%
Revenue Next 3Y-0.58%
Revenue Next 5Y0.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VTRS Yearly Revenue VS EstimatesVTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VTRS Yearly EPS VS EstimatesVTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.26, the valuation of VTRS can be described as very cheap.
  • Based on the Price/Earnings ratio, VTRS is valued cheaper than 95.29% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, VTRS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 5.76, the valuation of VTRS can be described as very cheap.
  • VTRS's Price/Forward Earnings ratio is rather cheap when compared to the industry. VTRS is cheaper than 94.76% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, VTRS is valued rather cheaply.
Industry RankSector Rank
PE 6.26
Fwd PE 5.76
VTRS Price Earnings VS Forward Price EarningsVTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 93.19% of the companies in the same industry are more expensive than VTRS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 91.62% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.42
EV/EBITDA 7.33
VTRS Per share dataVTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.3%
EPS Next 3Y1.4%

5

5. Dividend

5.1 Amount

  • VTRS has a Yearly Dividend Yield of 3.67%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.94, VTRS pays a better dividend. On top of this VTRS pays more dividend than 95.81% of the companies listed in the same industry.
  • VTRS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

  • VTRS has paid a dividend for at least 10 years, which is a reliable track record.
  • VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
VTRS Yearly Dividends per shareVTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y-2.3%
EPS Next 3Y1.4%
VTRS Yearly Income VS Free CF VS DividendVTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

VIATRIS INC

NASDAQ:VTRS (2/6/2026, 8:11:00 PM)

After market: 14.5 -0.08 (-0.55%)

14.58

+0.24 (+1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners86.94%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change0.07%
Market Cap16.79B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts72.22
Price Target13.39 (-8.16%)
Short Float %2.2%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)5.35%
PT rev (3m)11.74%
EPS NQ rev (1m)-0.41%
EPS NQ rev (3m)-1.36%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 6.26
Fwd PE 5.76
P/S 1.19
P/FCF 10.42
P/OCF 8.47
P/B 1.1
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)2.33
EY15.98%
EPS(NY)2.53
Fwd EY17.35%
FCF(TTM)1.4
FCFY9.6%
OCF(TTM)1.72
OCFY11.81%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.32
Profitability
Industry RankSector Rank
ROA -9.73%
ROE -24.26%
ROCE 4.32%
ROIC 3.41%
ROICexc 3.53%
ROICexgc 14.83%
OM 9.34%
PM (TTM) N/A
GM 39.36%
FCFM 11.41%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.96
Debt/EBITDA 3.05
Cap/Depr 13.37%
Cap/Sales 2.63%
Interest Coverage 250
Cash Conversion 48.4%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.79
Altman-Z 1.01
F-Score4
WACC8.19%
ROIC/WACC0.42
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.82%
EPS Next 2Y-2.3%
EPS Next 3Y1.4%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.74%
Revenue Next 2Y-1.77%
Revenue Next 3Y-0.58%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-4.89%
EBIT Next 3Y0.92%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%

VIATRIS INC / VTRS FAQ

What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VTRS.


What is the valuation status for VTRS stock?

ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.


What is the profitability of VTRS stock?

VIATRIS INC (VTRS) has a profitability rating of 5 / 10.


What is the valuation of VIATRIS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for VIATRIS INC (VTRS) is 6.26 and the Price/Book (PB) ratio is 1.1.


How sustainable is the dividend of VIATRIS INC (VTRS) stock?

The dividend rating of VIATRIS INC (VTRS) is 5 / 10 and the dividend payout ratio is -15.34%.